Эффективность заместительной гормонотерапии при сердечно-сосудистых заболеваниях у женщин в климактерическом периоде
Диссертация
Профилактическое и лечебное действие эстрогенов в отношении сердечно-сосудистых заболеваний в климактерическом периоде объясняют благоприятным влиянием эстрогенов на липиды крови, I процессы атерогенеза и сосудорасширяющим действием. При этом ЗГТ коррегирует явления остеопороза, а так же функциональные, иазомоторные и эмоционально-психические расстройства, типичные для климактерического периода… Читать ещё >
Содержание
- ВВЕДЕНИЕ.:."
- Глава 1. Обзор литературы
- Глава 2. Материалы и методы
- 2. 1. Характеристика базы и объекта исследования
- 2. 2. Программа «Комплексного исследования эффективности заместительной гормонотерапии при сердечно-сосудистых заболеваниях у женщин в климактерическом периоде»
- 2. 3. Клиническая характеристика пациенток
- 2. 4. Методы исследования
- 2. 4. 1. Суточное мониторирование ЭКГ
- 2. 4. 2. Суточное мониторирование АД
- 2. 4. 3. Велоэргометрия
- 2. 4. 4. Эхокардиография
- 2. 4. 5. Биохимия
- 2. 4. 6. Исследование качества жизни
- 2. 4. 7. Маммаграфия
- 2. 5. Используемые лекарственные средства, показания и противопоказания для ЗГТ
- Глава 3. Результаты заместительной гормонотерапии и их обсуждение
- 3. 1. Результаты ЗГТ при стенокардии
- 3. 2. Результаты ЗГТ при артериальной гипертонии
- 3. 3. Результаты ЗГТ при нарушениях ритма сердца
- 3. 4. Результаты ЗГТ при гиперхолестеринемии
- 3. 5. Изменение качества жизни при ЗГТ
- 3. 6. Побочные эффекты ЗГТ
Список литературы
- Бороян Р.Г. Клиническая фармакология для акушеров-гинекологов. // Москва: ООО «Мед. информационное агентство», 1997. 224 с.
- Вихляева Е.М. Постменопаузальный синдром и стратегиязаместительной гормональной терапии. // Акушерство и|гинекология. 1997. — №. 5. — С. 51−56.
- Горбаченков А.А., Поздняков Ю. М. Коронарный клуб. // Москва, ИЦПС «Единение». 1999. — 237 с.
- Государственный доклад о состоянии здоровья населения Российской Федерации в 2000 году. // М.: ГЕОТАР МЕД, 2001. -104 с.
- Грацианский Н.А. Заместительная терапия эстрогенами в менопаузе: реальный метод первичной и вторичной профилактики сердечнососудистых заболеваний у женщин или только интересная тема дляtобсуждения? // Клин. фарм. тер. 1994. — Т. 3. — №. 3. — С. 30−39.
- Грацианский Н.А. Гормональная заместительная терапия эстрогенами как метод профилактики (и лечения) атеросклеротических заболеваний сосудов у женщин в менопаузе. // Кардиология. 1996. — №. 6. — С. 4−17.
- Кобалава Ж.Д., Котовская Ю. В. Мониторирование артериального давления: методические аспекты и клиническое значение. М., 1999. — 234 с.
- Кудряшова О.Ю., Затейщиков Д. А., Сидоренко Б. Л. Возможная роль эстрогенов в профилактике и лечении атеросклероза у женщин после наступления менопаузы. // Кардиология. 1998. — №. — 4. — С. 51−61.
- Лякишев А.А. Коррекция дислипидемий у женщин в периоде постменопаузы. // Русский медицинский журнал. 2001. — Т. 9. — № 9.-С. 362−365.
- Морылева О.Н. Артериальная гипертония у женщин в постменопаузе: эффекты моэксиприла. // Автореферат дисс. канд. мед. наук М., — 1998. — 19 с.
- Сметник В.П. Климактерические расстройства и принципы заместительной гормонотерапии. // М: Materia Medika. 1996. — С. 163−169.
- Сметник В.П. Системные изменения у женщин в климактерии. // Русский медицинский журнал-. 20С1. — №. 9. — С. 354−357.
- Adams M.R., Register Т.С., Golden D.L. et al. Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis. //' Arteriescler. Thromb. Vase. Biol. -1997.-Vol 17.-P 217−221. •
- Albertsson P., Emanuellson H., Milson I. et al. Short-term effect of estrogen treatment in patients with syndrome X. // Circulation. 1994. -Vol. 90. — №. 4 — P. 3254.
- Albertson P., Emmanuellson H., Milson I. Beneficial effect of treatment with transdermal estradiol-17-beta on exercise-induced angina and ST segment depression in syndrome X. // Int. J. Cardiol. 1996. — Vol. 54. -№. l.-P. 13−20.
- Amoroso A., Garcia P., Ferri G.M. et al. «Hypertension and menopausal syndrome: effects of hormone replasement therapy and antihypertensivedrugs. // Riv. Eur. Sci. Med. Farmacol. 1996. — Vol. 18. — №. 4. — P. 149 152.
- Assman G., Schulte H. The impotance of triglycerides: results from the Prospective Cardiovascular Munster (PROCAM) Study. // Eur. J. Epidemiol. 1992. — Supll. 8. — P. 99 — 103.
- Bair D., Beisher N.A., Bygdeman M., et al. Clinical obstetrics and gynecology. // New York, 1988. Vol. 2. — P. 348.
- Barret-Connor E., Bush T.L. Estrogen and coronary heart diseas in women. // JAMA. -1991. Vol.- 265. — P. 1861−1867.
- Barret-Connor E. The gender gap in cardiovascular diseas: methodological issues (abstract). // Circulation. 1995. — Vol. 92. — №. 1. -P. I-B.
- Barret-Connor E., Wenger N.K., Grady D. et al. Guest editorial coronary heart disease in women, randomized clinical trials, HEARS and RUTH. // Maturitas 31.- 1998. P. 1−7.
- Benzer W., Schurz A.R., Drexel H. The effect of sublingual oestrogen administraishion on coronary blood flow in post-menopausal women with coronary artery diseas (abstract). // Eur. Heart J. 1995. — Vol. 16. — P. 387.
- Betteridge D.J., Morrell J.M. Clinicians' guide to Lipids and Coronary Heart Disease. // Chapman & Hall Medical.- London. 1998. — 276 p.
- Bhalla R.C., Toth K.F., Bhatty R.A. et al. Estrogen reduces proliferation and agonist-induces calcium increase in coronary artery smooth muscle cells. // Am. J. Physiol. 1997. — Vol 272: H1996. — P. 2003.
- Bjornntorp P. Regional patterns of fat distribytion. // Ann. Intern. Med. -1985.-Vol. 103.-P. 994−995.
- Bonithon- Kopp C., Scarabin P.Y., Darne B. et al. Menopause related changes in lipoproteins and some othes cardiovascular risk factors. // Int. J. Epidemiol. 1990. — Vol. 9. — P. 42−48.
- Boston Collaborative Drug Surveillance Group. Regular aspirin intakeand acute myocardial infarction. // B.M.J. 1974. — Vol. 1. — P. 440−443.»
- Brozozowski A.M., Pike A.C.W., Dauter Z. et al. Molecular basis of agonism and antagonism in the oestrogen receptor. // Nature. 1997. -Vol 389.-P. 753−758.
- Brussaard H.E., Gevers Leuven J.A., Kluft C. et al. Effect of 17 beta-estradiol on plasma lipids and LDL oxidation in postmenopausal women with type II diabetes mellitus. // Arterioscler. Thromb. Vase. Biol. 1997. -Vol. 17.-P. 324−330.
- Bush T.L., Barret-Connor E., Cowan L.D. et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. // Ciculation. 1987. — Vol. 75.-P. 1102−1109.
- Campos H., McNamara J.R., Ordovas J.M. et al. Differences in lowdensity lipoproteins subfractions and apolipoproteins in premenopausaland postmenopausal women. // J. Clin. Endocrin. Metabolism. 1988. -Vol. 67.-P. 30−35.
- Col N.F., Eckman M.N., Karas R.N., et al. Patient-specific decisions about hormone replacement therapy in postmenopausal women. // JAMA. 1997. — Vol. 277. — P. 1140−1147.
- Collaborative group on hormonal factors in breast cancer. Breast cancer and hormone replacement therapy: collaborative re-analysis of data from 51 epidemiological studies of 52 705 women with breast cancer. // Lancet. 1997. — Vol. 350. — P. 1047−1059.
- Collins R., Peto R., MacMahon S. et al. Blood pressure, stroke, andIcoronary heart disease. 2. Short-term reduction in blood pressure: overview of randomized drug trials in their epidemiological context. // Lancet. 1990. — Vol. 335. — P. 827−838.
- Crooc D. The metabolic consequences of treating postmenopausal women with non-oral hormone replacement therapy. // Br. J. Obstet. Gynaecol. 1997. — Vol. 104 (Suppl. 16). — P. 4−13.
- Davidson M.H., Testolin L.M., Maki K.S., et al. A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hyperholesterolemia in postmenopausal women. // Arch. Inter. Med. 1997. — Vol. 157. — P. 1186−1192.
- Dorr A.E., Gundersen K., Schneider J.C. Jr. et al. Colestipol hydrochloride in hypercholesterolemic patients effect on serum cholesterol and mortality. // J. Chronic. Dis. — 1978. — Vol. 31. — P. 5−14.
- Eaker E.D., Chesebro J.H., Sacks F.M. et al. Cardiovascular disease in women. // Circulation. 1993. — Vol. 88. — №. 4. — P. 1999−2009.
- Egashira K., Inou Т., Hirooka Y. et al. Evidence of impaired endotelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. // New Engl. J. Med. 1993. — Vol. 328. -P. 1659−1664.
- Epstein S.E., Cannon R.O. Site of increased resistance to coronary flow in patients with angina pectoris and normal epicardial coronary arteries. // J. Am. Coll. Cardiol. 1986. — Vol. 8. — P. 459−461.
- Farb A., Jacob A., Kolodgie F.D. et al. Reduced arterial neointima formation by 17beta-estradiol in ovariectomized rabbits: importance of smooth muscle cells migration. // Circulation. 1994. — Vol. 90. №. 4. -P. 1565.
- Farish E., Fletcher C., Hart D. et al. The effects of hormone implants on serum lipoproteins and steroid hormones in billaterally oophorectomised women. // Acta Endocrinol (Copenhagen). 1984. — Vol. 106. — P. 116 120.
- Folsom A.R., McGovern P.G. et al. Changes in plasma lipids and lipoproteins associated with starting or stopping postmenopausal hormone replacement therapy. // Am. Heart J. 1996. — Vol. 132. — P. 952−958.
- Frantz I.D., Dawson E.A.6 Ashman P.L. et al. Test of effect of lipid lowering by diet on cardoivascular risk: the Minnesota Coronary Survey. // Arteriosclerosis. 1989. — Vol. 9. — P. 129−135.
- Framingham Heart Study Monograph №.34. Bethesda, Md- US Dept. of Health and Human Services.
- Gaspard U.J. // Evaluation of the cardiovascular impact of hormonal replacement therapy in menopausal women. J. Ginecol. Obstet Biol. Reprod. Paris. — 1996. — Vol. 25. — №. 7. — 671−676.
- Gerhard M., Walsh B. W., Tawacol A. et al. Estradiol therapy combined with progesterone and endothelium-depend vasodilation in postmenopausal women. 1998. — Vol 98. — P. 1158 — 1163.
- Gilligan D.M., Badar D.M., Panza J.A. et al. Acute vascular effect of estrogen in postmenopausal women. // Ibid. 1990. — P. 786−791.
- Gilligan D.M., Quyyumi A.A., Cannon R.O. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. // Circulation. 1994. — Vol. 89. — P. 2545−2551.
- Gisburg J. Ovarian Hormones and vascular function. In: Lippert TH., Meusk AO., Ginsburg J., editors. Sex Steroids and the Cardiovascular System. New York: Parthenon, 1996. P. 3 — 20.
- Gordon Т., Kannel W.B. Drinking habits and cardiovascular desease: the Framingham Study. // Am. Heart J. 1983. — Vol. 105. — P. 667−673.
- Grady D., Rubin S., Pettiti D. Hormone therapy to prevent disease and prolong life in postmenopausal women. // Ann. Intern. Med. 1992. -Vol. 117.- P. 1016−1037.
- Graham J. Coronary artery disease and women. // BMJ. 1994. — Vol. 309.-№.3.-P. 555−556.
- Gelfand M. Cardiovascular risk-factors during sequentially combened 17 beta-oestradiol and dydrogesterone (Femoston) — results from a one-yearstudy in postmenopausal women. I I Maturitas. 1997. — Vol. 26. — P. 125 132.
- Genant H.K., Lucas J., Weiss S., et al. Low-dose esterified estrogen therapy: effets on bone, plasma estradiol concentrations, endometrium and lipid levels. Estratab/Osteoporosis Study Group. // Arch. Intern. Med. 1997. — Vol. 157. — P. 2609−2615.
- Grodstein F., Stamfer M.J., Colditz G.A., et al. Postmenopausal hormone therapy and mortality. // N. Engl. J. Med. 1997. — Vol. 336. — P. 17 691 775.
- Gruchow H.W., Anderson H.J., Barboriak J.J., Sobocinski K.A. л ostmenopausal use of estrogens and occlusion of coronary arteries. // Am. Heart J. 1988. — Vol. 115. — P. 954−963.
- Hammond E.C., Garfinkel L. Aspirin and coronary heart disease: finding of a prospective study. // B.M.J. 1975. — Vol. 2. — P. 269−271.
- Hammond C.B., Jelovsek F.R., Lee K.I. et al. Effect of estrogen replacement therapy. I. Metabolik effects. // Am. J. Obstet Gynecol -1979.-Vol. 133.-P. 526−536.
- Hanke H., Hanke S., Dauble C. et al. Effect of estrogen and progesteron on smooth muscle cells proliferation in experimental atherosclerosis. // Circulation. 1994. Vol. 90:4:2. — P1564.
- Hartz A., Grubb В., Wild R. et al. The association of waist hip ratio and angiographically determined coronary artery disease. // Int. J. Obes. -1990.-Vol. 14.-P. 657−665.
- Hebert P.R., Moser M., Mayer J. et al. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart desease. // Arch. Intern. Med. 1993. — Vol. 153. — P. 578−581.
- Henderson B.E., Paganini-Hill A., Ross R.K. Decreased mortality in users of estrogen replacement therapy. // Arch. Intern. J. 1991. — Vol. 151.-P. 75−78.
- Hennekens C.H. Clinical and research challenges in risk factors for cardiovascular diseases. Eur. Heart J. — 2000. — Vol. 21. — P. 19 171 921.
- Hodgkinson A. Plasma electrolyte concentration in women and the effects of estrogen administration. // Maturitas. 1982. — Vol. 4. — P. 247−256.
- Hubert H.B., Feinleib M., McNarr^ra P.M. et al. Obesity as an independent risk factor for cardiovascular desease: a 26-years follow-up of participans in the Framingham Heart Study. // Circulation. 1983. -Vol. 67. — P. 968−977.
- Ingegno M.D., Money S.R., Thelmo W. et al. Progesterone receptors in human heart and great vessels. // Lab. Invest. 1988. — Vol 59. — P. 353 -356.
- Jackson G. Hypertension in Women. // Schwarz pharma. Martin Dunitz Ltd.- 1996.-88 p.
- Jamin С. Estrogen replacement therapy: myth or reality? // Contracept Fertil. Sex. 1997. — Vol. 25. — №. 10. — P. 793−797.
- Jensen J., Nilas L., Christiansen C. Influence of menopause on serum lipids and lipoproteins. // Maturitas. 1990. — Vol. 12. — P. 321−331.
- Jiang C., Sarrel P.M., Lindsay D.C. et' al. Endotelium- independent relaxation of rabbit coronary artery by 17 beta-oestradiol in vitro. // Br. J. Pharmacol. -1991. — Vol. 104. — P. 1033−1037.
- Karas R.H., Patterson B.L., Mendelsohn M.E. Human vascular smooth muscle cells contain functional estrogen receptor. // Circulation. 1994. -Vol 89.-P. 1943- 1950.
- Kaski J.C., Tousoulis D., Galassi A.R. et al. Epicardial coronary artery tone and reactivity in patients with normal coronary arteriograms and reduced coronary flow reserve (syndrome X). // J. Am. Coll. Cardiol. -1991.-Vol. 18.-P. 50−54.
- Kern M.J. Extracting the coronary artery from syndrome X: is epicardial vasomotion physiologic in patients with normal coronary arteriograms and reduced coronary flow reserve? // J. Am. Coll. Cardiol. -1991. Vol. 18.-P. 55−56.
- Kiuper G.G., Carlsson В., Grandien K. et al. Comparison of the lig and binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. // Endocrinology. 1997. — Vol 138. — P. 863- 870.
- Klatsky A.L., Friedman G.D., Siegelaub A.B. Alcohol consumption before myocardial infarction: result from the Kaiser-Permanente epidemiologic study of myocardial infarction. // Ann. Intern. Med. -1974.-Vol. 81.-P. 294−301.
- Klein W. Cardiovascular disease at the turn of the millennium: focus on Europe.//European Heart Journal (Suppl.) 2001. — Vol. 3 (Suppl. M). — P. 2−6.
- Krasinski К., Spyridopoulos I., Asahara T. et al. Estradiol accelerates functional endothelial recovery after arterial injury. // Circulation. -1997. Vol 95. — P. 1768 — 1772.
- Krauss R.M. Effects of progestational agents on serum lipids and lipiproteins. // J. Reprod. Med. 1982. — Vol 27. — P. 503 — 510.
- Krauss R.M. Plazma lipids and lipoproteins. Hormon replacement therapy and the cardiovascular system. Resent advances. // Ed. J. Stevenson. Abington UK. The medicine gfoup. 1995. — P. 12−17.
- La Croix A.Z., Lang J., Scherr P. et al. Smoking and mortality among older men and women in three communities. // N. Engl. J. Med. -1991. -Vol. 324.-P. 1619−1625.
- Lauritzen C. A critical European view of the HERS trial. // Maturitas 31. 1998.-P. 15−19.
- Levin E.R. Ovarian steroids modulate vascular cell physiology. // The Endocrine Society Annual Meeting, 79th: Program and abstracts. Minneapolis: Minnesota 1997. P. 2−13.
- Lew E.A., Garfinkel L. Variation in mortality by weight among 750,000 men and women. // J. Chronic. Dis. 1979. — Vol. 32. — P. 563−576.
- Ley C.J., Lees В., Stevenson J.C. Gender and menopause associated changes in body fat distribution. // Am. J. Clin. Nutr. 1992. — Vol. 55. -P. 950−954.
- Lindoff C., Peterson F., Lecanider I.' et al. Trandermal estrogen replacement therapy: beneficial effects on hemostatic risk factors for cardiovascular disease. // Maturitas. 1996. — Vol. 24. — №. 1−2. — P. 4350.
- Linquist О. Intraindividual changes in blood pressure, serum lipids and body weight in relation to menstrual status: results from prospective population study of women in Goteborg, Sweden. Prev Med 1982. Vol. 11.- P. 162−172.
- Magnus K., Matroos A., Strackee J. et al. Walking, cycling, or gardening, with or without seasonal interruption, in relation to acute coronary events. // Am. J. 1979. — Vol. 110.'- P. 724−733.
- Manson J.E., Colditz G.A., Stapfer M.J. et al. A prospective study of obesity and risk of coronary heart disease in women. // N. Engl. J. Med. -1990.-Vol. 322.-P. 882−889.
- Manson J.E., Stampfer M.J., Colditz G.A. et al. A prospective study of aspirin use and primary prevention of cardiovascular disease in women. //JAMA.-1991. Vol. 266.-P. 521−527.
- Manson J.E., Stampfer M.J., Willet W.C., et al. A prospective study of antioxidant vitamins and incidence of coronary heart disease in women. // Circulation. -1991. Vol. 84 (Suppl. II), — P. 546.
- Manson J.E., Tosteson H., Ridker P.M. et al. The primary prevention of myocardial infarction. // N. Engl. J. Med. 1992. — Vol. 326. — P. 14 061 416.
- Maseri A., Crea F., Kaski J.C. et al. Mechanisms of angina pectoris in syndrome X. // J. Am. Coll. Cardiol. -1991. Vol. 17. — P. 499−506.
- Matthews K.A., Meilahn E., Kuller L.H. et al. Menopause and risk factors for coronary heart disease. //N. Engl. J. Med. 1989. — Vol. 321. -P. 641−646.
- Mendelsohn M.E., Karas R. The protective effects of estrogen on the cardiovascular system. //N. Engl. J. Med. 1999. — Vol 340.-P. 1801 -1811.
- Mercuro G., Zoncu S., Cherchi A. Effects of transdermal estradiol 17b on hypertension in postmenopausal women. // J. Am. Coll. Cardiol. 1996 -Vol. 27 (Suppl. A). — P. 981−982.
- Mercuro G., Longu G., Zoncu S. et al. Impaired forearm blood flow and vasodilator reserve in healthy postmenopausal women. // Am Heart J. -1999.-Vol 137.-P. 692−697.
- Mercuro G., Pitzalis L., Podda A. et al. Effects of acute administration of natural progesterone on peripheral vascular responsiveness in healthy postmenopausal women. // Am. J. Cardiol. 1999. — Vol 84. — P. 214 -218.
- Mercuro G., Zoncu S., Rosano M.C. Mechanisms of cardiovascular activity of ovarian hormones. // European Heart J. Suppl. 2000 — Vol. 2 (Suppl.G) — P. 2−6.
- Mijatovic V., Kenemans P., Jakobs C. et al. A randomized controlled study of the effects of 17-beta-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women. // Obstet Gynecol. 1998. -Vol 91.-P. 432−436.
- O' Brien J.E., Peterson E.D., Keeler E.D. et al. Relation between estrogen replacement therapy and restenosis after percutaneous coronary intervention. // J. Am. Coll. Cardiol. 1996. — Vol. 28. — P. 1111−1118.
- O' Brien Т., Nguyen T.T. Lipids and lipoproteins in women. // Mayo. Clin. Proc. 1997. — Vol. 1997. — P. 235−244.13 Ъ ^
- О' Keefe J.H.Jr., Kim S.C., Hall R.R. et al. Estrogen replacement therapy after coronary angioplasty in women. // J. Am. Coll. Cardiol. 1997. -Vol. 29. — №. l.-P. 1−5.
- Paganini-Hill A., Ross R.K., Henderson B.E. Postmenopausal oestrogen treatment and stroke: a prospective study. // B.M.J. 1988. — Vol. 297. -P. 519−522.
- Paganini-Hill A., Chao A., Ross R.K. et al. Aspirin use and chronic disease: a cohort study of the elderly. // B.M.J. 1989. — Vol. 299. — P. 1247−1250.
- Peti4! D.B., Wingerd J., Pellegrin F. et al. Risk of vascular disease in women: smoking, oral contraceptives, noncontraceptive estrogens, and other factors. // JAMA. 1979. — Vol. 242. — P. 1150−1154.
- Pilote L., Hlatky M.A. Attitudes of women towards hormone therapy and prevention of heart disease. // A. M. Heart J. 1995. — Vol. 129. — P. 1237−1238.
- Pines A., Mijatovic V., van-der-Mooren M.J. et al. Hormone replacement therapy and cardioprotection: basic concepts and clinical considerations. // Eur. J. Obstet. Gynecol. Reprod. Biol, у 1997. Vol. 71. — №. 2. — P. 193−197.
- Posner B.M., Cupples L.a., Miller D.R. et al. Diet, menopause and serum cholesterol levels in women: the Framingham Study. // Am. Heart J. -1993.-Vol. 125.-P. 483−489.
- Prevention of coronary heart disease in clinical practice. Recomendation of the Second Joint Task Force of Europeans and other Societies on coronary prevention. // Eur. Heart. J. 1998. — Vol. 19. — P. 1434−1503.
- Pripp U., Hall G., Csemiczky et al. A randomized trial on effects of• ¦¦ «hormone therapy on ambulatory blood pressure and lipoprotein levels in women with coronary artery disease. // J. Hypertension. 1999. — Vol 17.-P. 1379- 1386.
- Psaty B.M., Heckbert S.R., Atkins D. et al. The risk of myocardial infartion associated with the combined use of estrogens and progestins in postmenopausal women. // Arch. Ihtern. Med. 1994. — Vol. 154. — P. 1333- 1339.
- Reczuch K., Ponikowski P., Pobrotyn P. Et al. Pretest risk stratification is necessary to improve the diagmostic value of exercise testing in women. // Eur. Heart J. 1997. — Vol. 18. (Abstr. Suppl.) — P. 331.
- Reis S.E., Gloth S.T., Blumenthal R.S. et al. Estrogen acutely abolishes cold-induced coronary vasoconstriction in postmenopausal women. // Circulation. 1994. — Vol. 89. — P. 52−60.
- Rich-Edwards J.W., J.E. Manson, Charles H. Hennekens et al. The primary prevention of coronary ЬёаЛ disease in women. // N. Engl. J. Med. 1995. — Vol. 332. — № 26: — P. 1758−1765.
- Ridker P.M. Intercellular adhesion molecule (ICAM-1) and the risk of developing atherosclerostic disease. // Eur. Heart J. 1998. — Vol. 19. -P.1119−1121.
- Ridker P.M., Hennekens C.H., Rifai N. et. al. Hormone replacement therapy and increased plasms concentration of C-reactive protein. // Circulation. 1999. — Vol 100. — P. 713- 716.
- Riflci V.A., Khachadurian A.K. The ingibition of low-density lipoproteins oxidation by 17 beta-estradiol. // Metabolism. 1992. — Vol. 41.-P. 1110−1114.
- Rosano G.M.C., Lindsay D.C., Sarrel P.M. et al. Beneficial effects of oestrogen replacement treatment in normalising skin blood flow inpatients with syndrome X Abstract. // Clin. Sci. 1990. — Vol. 8. — P. 910.
- Rosano G.M.C., Lindsay D., Kaski J.C. et al. Syndrome X in women: the importance of ovarian hormones Abstract. // J. Am. Coll. Cardiol. -1992.-Vol. 19/3.-P. 254A.
- Rosano G.M.C., Sarrel P.M., Pool-Wilson P.A., Collins P. Beneficial effekt of oestrogen on exercise-unduced myokardial ishaemia in women with coronary artery disease. // Lancet. 1993. — №. 342. — P. 133−136.
- Rosano G.M.C., Caixeta A.M., Arie S. et al. Acute anti-ishemic effect of estradiol 17b in menopausal women with coronary artery diseas. // J. Am. Coll. Cardiol. 1996. — №. 27 (Suppl. A). — P. 934−977.
- Rosano G.M.C., Cherchia S.L., Leonardo f. et al. Cardioprotective effect of ovarian hormones. // Eur. Heart J. 1996. — Vol. 17 (Suppl. D). — P. 1519.
- Rosano G.M.C., Peters N.S., Lefr6y D. et al. 17-beta-Estradiol therapy lessens angina in postmenopausal women with syndrome X. // J. Am. Coll. Cardiol. 1996. — Vol. 28. — №. 6. — P. 1500−1505.
- Rosano G.M.C., Pereira W.I., Sheiban I. et al. Acute administration of estradiol 17-beta reduces cardiac release of endotelin-1 in women with coronary artery disease. // European Heart J. 1997. — Vol. 18. — P. 558.
- Rosano G.M.C., Fini M., Onorati D., Mercuro G. Hormone replacement therapy and /or lipid-lowering drugs for menopausal women with hypercholesterolaemia. // European Heart J. 2000. — Vol. 2 — Suppl. G. -P. 7−14.
- Rosano G.M.C., Patrizi R., Leonardo F. et al. Effects of estrogen replacement therapy upon heart rate variability in healthy postmenopausal women. // A. J. Cardiol. 1997. — Vol. 80. — P. 815 — 817.1 «
- Rosano G.M.C., Leonardo F., Pellicia F. et al. Different antiischemic effect of estrogen and testosterone in men and women with coronary artery disease. // J. Am. Coll. Cardiol. (Supll. 1 A). 2000. — Vol 35. — P. 1045−1046.
- Rosenberg L., Slone D., Shapiro' S. et"al. Alcoholic beverages and myocardial infarction in young women. // Am. J Epidemiol. 1987. -Vol. 71.-P. 82−85.
- Rosenberg L., Palmer J.R., Shapiro S. Decline in the risk of myocardial infarction among women who stop smoking. // N. Engl. J. Med. 1990. -Vol. 322.-P. 207−213.
- Rosselli M., Keller P.J., Kern F. Estradiol ingibits mitogen-induced proliferation and migration of human aortic smooth muscle cells: implifications for cardiovascular disease in women. // Circulation. -1994.-Vol. 90.-№ 4.-P. 0461. '
- Ruderman N.B., Haudenschild C. Diabets as an atherogenic factor. // Prog. Cardiovasc. Dis. 1984. — Vol. 26. — P. 373−412.
- Rymer J., Crook D., Sidhu H. et al. Effects of tibolone on serum concentrations of lipoprotein (a) in postmenopausal women. // Acta Endocrinol (Copenhagan). 1993. — Vol. 128. — P. 259−262.
- Sack M.N., Rader D.J., Cannon R.O. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. // Lancet. 1994. — Vol. 343. — P. 269−270.
- Salonen J.T., Puska P., Tuomilehto J. Physical activity and rick of myocardial infarction, cerebral stroke and death: a longitudinal study in eastern Finland. // Am. J. Epidemiol. 1982. — Vol. 115. — P. 526−537.
- Samaan S.A., Crawford M.H. Estrogen and cardiovascular fuction after menopause. 11 J. Am. Coll Cardiol. 1995. — Vol. 26. — P. 1403−1410.
- Sarrel P.M. Ovarian hormones and circulation. // Maturitas. 1990. -Vol. 12.-P. 287−298.
- Sax F.L., Cannon R.O., Hanson C. et al. Impaired forearm vasodilatator reserve in patients with microvascular angina. // New Engl. J. Med. -1987.-Vol. 317.-P. 1366−1370.
- Sbarouni E., Kroups C., Kyriakides Z.S. et al. Cell adgision molecules in relation to simvastatin and hormone replacement therapy in coronary artery disease. // Eur. Heart J. 2000. — Vol. 21. — P. 975−980.
- Schench Gustafsson K., Swahn E. Guidelines for the European cardiologist concerning hormone replacement therapy in postmenopausal women. // European Heart J. — 2000 — Vol 2. — Suppl.G. — P. 15 — 16.
- Schunkter H., Danser A.H.J., Hense H.W. et al. Effects of estrogen replacement therapy on the rennin-angiotension system in postmenopausal women. // Circulation. 1997. — Vol 95. — P. 39−45.
- Schuz R.A., Benzer W. Hormone replacement in postmenopausal women with coronary heart disease. Results and clinical consequences from recent studies. // Wien. Klin. Wochenschr. Suppl. 1997. — Vol. 2. — P. 42−45.
- Schwartzman R.A., Crook R., Cole D. et al. Elevated plasma lipoprotein (a) is independently associated with the severity of coronary artery disease in male and female patients with chronic stable angina. // European Heart J. 1997. — Vol. 18. — P. 485.
- Scragg R., Stewart A., Jackson R. et al. Alcohol and exercise in myocardial infarction and sudden coronary death in men and women. // Am. J. Epidemiol. 1987. — Vol, 126. — P. 77−85.
- Sellers T.A., Mink P.J., Cerhan J.R., et al. The role of hormone replacement therapy in risk for breast cancer and total mortality in women with a family history of breast cancer. // Ann. Intrn. Med. 1997. -Vol. 127.-P. 973−980.
- Shear W.S., Haidet G.C., Bank A.J. et al. Single-dose estrogen reduced exercise- induced myocardial ischamia in postmenopausal women with microvascular coronary artery diseas. // Circulation. 1994. — Vol. 90. -№.4.-P. 0134.1 «
- Simon Т., Jallion P. Hormone replacement therapy in postmenopausal women at cardiovascular risk: epidemiology and clinical trials. // European Heart J. 2000 — Vol. 2. — Suppl. G. — P. 2 — 6.
- Speroff L. The Herart and Estrogen/Progestin Replacement Study (HERS). // Maturitas 31. 1998. — P. 9−14.»
- Staessen J.A., Bullpitt C.J., Fogart R. et al. The influence of menopause on blood pressure. //J. Hum. Hypertens. 1989. — Vol. 3. — P. 427−433.
- Stampfer M.J., Colditz G.A., Willett W.C. et al. A prospective study of moderate alcohol consumption and the rick of coronary disease and stroke in women. // N. Engl. J. 1988. — Vol. 319. — P. 267−273.
- Stampfer M.J., Colditz G.A. Estrogen replacement therapy and coronary heart desease: quantitative assessment of the epidemiologic evidence. // Prev. Med. 1991. — Vol. 20. — P. 47−63.
- Stampfer M.J., Colditz G.A., Willett W.C. et al. Postmenopausal"estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses Health Study. // N. Engl. J. 1991. — Vol. 325. — P. 756−762.
- Stampfer M.J., Hennekens C.H., Manson J.E., et al. Vitamin Econsumption and the risk of coronary disease in women. // N. Engl. J.1 «
- Med. 1993. — Vol. 328. — P. 1444−1449.
- Stevenson J., Crook D., Godsland I. Effects of age and menopause on lipid metabolism in healthy women. 1993. — Atherosclerosis. — Vol. 98. -P. 83−90.
- Sullivan J.M., Zwaag V.R., Lemp G.F. et al. Postmenopausal estrogen use and coronary atherosclrrosi. // Ann. Intern. Med. 1988. — Vol 108. -P. 358−363.
- Sullivan J.M., Zwaag V.R., Hughes J.P. et al. Estrogen replacement and coronary heart disease: effect on survival in postmenopausal women. // Arch. Intern. Med. 1990. — Vol. 150. — P. 2557−2562.
- Sullivan J.M., El-Zeky F., Zwaag R.W., Ramanathan K.B. Effect on survival of estrogen replacement therapy afther coronary artery bypass grafting. // Am. J. Cardiol. 1997. — Vol. 79. — P. 847−850.
- Tanno K., Kobayashi Y., Baba T. Pretest risk stratification is nececary to improve the diagnostic value of exercise testing in women. // European Heart J. 1997.-Vol. 18.-P. 331.
- The Writting Group for the PEPI Trial. Effect of estrogen or estrogen/progestin regimens on heart diseas risk factors in postmenopausal women. The postmenopausal Estrogen/Progestin Intervention (PEPI). // Trial. JAMA. 1995. — Vol. 273. — P. 199−208.
- U.K. Prospective Diabetes Study 27: plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex. // Diabetes Care. 1997. — Vol. 20. -P. 1683−1687.
- Van Beresteijn E.C.L.H., Riedstra M., Van der Wei A. Et al. Habitualdietary calcium intake and blood prresure change around the menopause:1 «a longitudinal study. // Int. J. Epidemiol. -1992. Vol. 21. — P. 683−689.
- Van der Mooren M.J., Demacker P.M., Blom H.J. et al. The effect of seqeential three-monthly hormone replacement therapy on several cardiovascular risk estimators in postmenopausal women. // Fertil. Steril. 1997.-Vol. 67.-P. 67−73.
- Walsh B.W., Schiff I., Rosner B. et al. Effect of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. //N.Engl. J. Med. -1991. Vol. 325.-P. 1196−1204.
- Welsh C.J.P., McLenachan J.M. Effect of oestrogen replacement therapy on angina symptoms and exercise ЁСв in’post-menopausal women with coronary artery disease. // Eur. Heart J. 1997. — Vol. 18. (Abstr. Suppl.). — P. 556.
- Whiteman J.C.M., Grobbee D.E., Kon F.J. et al. Increased risk of atherosclerosis in women after menopause. // Br. Med. J. 1989. — Vol. 298. — P. 642−644.
- Willet W., Stampfer M.J., Bain C. et al. Cigarette smoking, relative weight and menopause. // Am. J. Epidemiol. 1983. — Vol. 117. — P. 651−658.
- Willet W.C., Green A., Stampfer Nt.J. et al. Relative and absolute excess rick of coronary heart disease among women who smokes cigarettes. // N. Engl. J. Med. 1987. — Vol. 317. — P. 1303−1309.
- Williams J.K., Honore E.K., Washburn S.A. et al. Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. // J. Am. Coll. Cardiol. 1994. — Vol 24. — P. 1757- 1761.
- Williams J.K., Kim Y.D., Adams M.R. et al. Effect of estrogen on cardiovascular responses of premenopausal monkeys. // J. Pharmacol. Exp. Ther. 1994. — №. 271. — P. 671−676.1
- Women’s Health Initiative Study. Group design of the Women’s Health Initiative Clinical Trial and observation study. // Control. Clinic. Trial. -1998.-Vol. 19. P. 61−109.
- Zoncu S., Piano D., Pilia I. et’al. Estradiol-17-beta reduces blood pressure and restores the normal amplitude of the circadian blood pressure rhythm in postmenopausal hypertension. // European Heart J. -1997.-Vol. 18.-P. 557.